Nick Lemoine

Last updated

Nicholas Robert Lemoine

BornDecember 1957
Ealing, Middlesex [1]

Nicholas Robert Lemoine, [2] CBE , FRCPath , FMedSci (born December 1957 [3] ) is a British academic, professor at Queen Mary University of London, director of the Barts Cancer Institute and centre lead, Centre for Molecular Oncology. [4] [5]

Lemoine's main interests are "the genomics and molecular pathology of pancreatic cancer and the development of oncolytic virotherapy". [5]

He was educated at Abingdon School [6] from 1971 until 1976 before studying medicine at St Bartholomew's Hospital Medical College from 1977 until 1983. [7]

Lemoine was appointed Commander of the Order of the British Empire (CBE) in the 2022 New Year Honours for services to clinical research, particularly during COVID-19. [8]

See also

Related Research Articles

<span class="mw-page-title-main">Barts and The London School of Medicine and Dentistry</span> Part of Queen Mary University, London, England

Barts and The London School of Medicine and Dentistry, commonly known as Barts or BL, is a medical and dental school in London, England. The school is part of Queen Mary University of London, a constituent college of the federal University of London, and the United Hospitals. It was formed in 1995 by the merger of the London Hospital Medical College and the Medical College of St Bartholomew's Hospital .

<span class="mw-page-title-main">Cancer Research UK</span> Cancer research and awareness charity

Cancer Research UK (CRUK) is the world's largest independent cancer research organisation. It is registered as a charity in the United Kingdom and Isle of Man, and was formed on 4 February 2002 by the merger of The Cancer Research Campaign and the Imperial Cancer Research Fund. Cancer Research UK conducts research using both its own staff and grant-funded researchers. It also provides information about cancer and runs campaigns aimed at raising awareness and influencing public policy.

<span class="mw-page-title-main">Medical Research Council (United Kingdom)</span> National medical research agency

The Medical Research Council (MRC) is responsible for co-coordinating and funding medical research in the United Kingdom. It is part of United Kingdom Research and Innovation (UKRI), which came into operation 1 April 2018, and brings together the UK's seven research councils, Innovate UK and Research England. UK Research and Innovation is answerable to, although politically independent from, the Department for Business, Energy and Industrial Strategy.

The Institute of Cancer Research is a public research institute and a member institution of the University of London in London, United Kingdom, specialising in oncology. It was founded in 1909 as a research department of the Royal Marsden Hospital and joined the University of London in 2003. It has been responsible for a number of breakthrough discoveries, including that the basic cause of cancer is damage to DNA.

The Christie NHS Foundation Trust in Withington, Manchester, manages the Christie Hospital, one of the largest cancer treatment centres of its type in Europe. The Christie became an NHS Foundation Trust in 2007 and is also an international leader in cancer research and development, home to the Paterson Institute for Cancer Research.

<span class="mw-page-title-main">Beatson West of Scotland Cancer Centre</span> Specialised cancer care centre in Glasgow, Scotland

The Beatson West of Scotland Cancer Centre is a specialised cancer care centre in Glasgow, Scotland. Until recently it had facilities in Gartnavel General Hospital, the Western Infirmary and Glasgow Royal Infirmary. As part of the NHS Greater Glasgow and Clyde Acute Services Review, the centre is being centralised within new facilities at the Gartnavel General Hospital site.

Karol Sikora is a British physician specialising in oncology, who has been described as a leading world authority on cancer. He was a founder and medical director of Rutherford Health, a company that provided proton therapy services, and is Director of Medical Oncology at the Bahamas Cancer Centre.

<span class="mw-page-title-main">Jonathan Simons</span> American oncologist

Jonathan W. Simons is an American physician-scientist, medical oncologist, and leader in prostate cancer research. In August 2021, Simons was appointed the medical director and Chief Science Officer of the Marcus Foundation. Prior to joining the Marcus Foundation, he served a 14-year tenure as the President and chief executive officer of the Prostate Cancer Foundation. Simons’ laboratories, partly funded by the Prostate Cancer Foundation, at Johns Hopkins University and Emory University made original contributions to understanding the molecular biology of prostate cancer metastasis and principles of “broken immune tolerance” via T cell based immunotherapy for prostate cancer. The Simons lab invented GM-CSF genetically engineered vaccines for prostate cancer in rodents and humans for these studies, and subsequently Simons’ clinical team took the biotechnology into the world’s first human gene therapy clinical trials for advanced prostate cancer at Johns Hopkins.

<span class="mw-page-title-main">Oncology</span> Branch of medicine dealing with, or specializing in, cancer

Oncology is a branch of medicine that deals with the study, treatment, diagnosis and prevention of tumors. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass". Oncology is concerned with:

Frances Rosemary Balkwill is an English scientist, Professor of Cancer Biology at Queen Mary University of London, and author of children's books about scientific topics.

<span class="mw-page-title-main">Hani Gabra</span>

Hani Gabra PhD FRCPE FRCP is a British oncologist and Professor Emeritus in Medical Oncology at Imperial College London.

Alan Ashworth, FRS is a British molecular biologist, noted for his work on genes involved in cancer susceptibility. He is currently the President of the UCSF Helen Diller Family Comprehensive Cancer Center at the University of California, San Francisco, a multidisciplinary research and clinical care organisation that is one of the largest cancer centres in the Western United States. He was previously CEO of the Institute of Cancer Research (ICR) in London.

<span class="mw-page-title-main">Michael Adrian Richards</span> Oncologist and cancer researcher

Professor Sir Michael Adrian Richards, CBE, MD, DSc (Hon), FRCP is a British oncologist. From 1999 to 2013 he was the National Cancer Director in the UK Government's Department of Health. He was appointed to be the Chief Inspector of Hospitals in the Care Quality Commission on 31 May 2013. and was said by the Health Service Journal to be the third most powerful person in the English NHS in December 2013.

Sir John Robert Hills, was a British academic, latterly professor of Social Policy at the London School of Economics. He acted as director of the ESRC Research Centre for the Analysis of Social Exclusion from 1997. His work focused on inequality, and the role of social policy over the life course.

<span class="mw-page-title-main">Edinburgh Cancer Research Centre</span> Medical facility in City of Edinburgh, Scotland, UK

The Edinburgh Cancer Research Centre (ECRC), also known as the Cancer Research UK Edinburgh Centre and the University of Edinburgh Cancer Research Centre, is a center for basic, translational and clinical cancer research located in Edinburgh, Scotland. ECRC constitutes a part of the Institute of Genetics & Molecular Medicine (IGMM) and is positioned in direct proximity of the Western General Hospital, where most of its clinical activities take place.

<span class="mw-page-title-main">Jane Plant</span> British geochemist, scientist, author, engineer

Jane Anne Plant CBE, FREng, FRSE, FRSA (1945–2016) was a leading geochemist, scientist, and author. Plant was a pioneer in the field of geochemical surveys and environmental surveys. She was Chief Scientist at the British Geological Survey and was a Professor of Geochemistry at Imperial College London. Plant was also highly involved in the Institution of Mining & Metallurgy where she was involved in many aspects including a role on the Council, and was the first female President of the Institution of Mining & Metallurgy, a post she held from 2001 to 2002. This gave her an extensive network of key connections with government, industry and academia.

Irene May Leigh CBE FRSE FMedSci is a British dermatologist. A former professor of Barts and The London School of Medicine and Dentistry, she is now a professor emeritus at the University of Dundee School of Medicine. Her research has focused on keratinocytes, non-melanoma skin cancers and genetic skin diseases. She was elected to the Academy of Medical Sciences in 1999 and appointed CBE in 2012.

<span class="mw-page-title-main">Caroline Dive</span> Professor of Cancer Pharmacology

Caroline Dive is a British cancer research scientist. Dive is Professor of Cancer Pharmacology at the University of Manchester, Deputy Director of the Cancer Research UK (CRUK) Manchester Institute, Director of the CRUK Manchester Institute Cancer Biomarker Centre and co-director of the CRUK Lung Cancer Centre of Excellence. She is the current President of The European Association for Cancer Research (EACR).

<span class="mw-page-title-main">Andrew Biankin</span>

Andrew Victor Biankin is a Scotland-based Australian clinician-scientist, best known for his work on enabling precision oncology in learning healthcare systems by integrating discovery, preclinical and clinical development to accelerate novel therapeutic strategies, and developing standardised pan-cancer assays for use by healthcare systems and researchers worldwide.

The University of Glasgow's Glasgow Precision Oncology Laboratory (GPOL) is a molecular research facility that partners with the NHS and industry to perform research into the development of novel therapeutic strategies, the creation of pan-cancer genomic assays and provide knowledge transfer for healthcare systems to enable them to develop landscapes for therapeutic testing in cancer.

References

  1. "Births". Free BMD.
  2. "Foreign Academicians Bring Global Perspective to Chinese Scientists". English Chinese Academy of Sciences.
  3. "Nicholas LEMOINE - Personal Appointments (free information from Companies House)" . Retrieved 10 December 2016.
  4. "Meet the researchers - Professor Nick Lemoine · What we do · Pancreatic Cancer Research Fund" . Retrieved 10 December 2016.
  5. 1 2 Lemoine, Nick. "Professor Nick Lemoine - Barts Cancer Institute" . Retrieved 10 December 2016.
  6. "Officers of the School" (PDF). The Abingdonian.
  7. "Nick Lemoine". oncology-central.com.
  8. "No. 63571". The London Gazette (Supplement). 1 January 2022. p. N9.